Clinical trial Recruiting at 1 site Interventional Ages 16 to 20

Transition care for adolescents with congenital heart disease

Official title: The Effect of Structured Transition Care Model Applied to Adolescents With Congenital Heart Disease on Transition Readiness, Self-Management Skills and Care Satisfaction

Run by Ankara Yildirim Beyazıt University · NCT06433401 · Data updated 2026-11-12

This study tests a new support program to help teenagers with congenital heart disease smoothly transition to adult healthcare and learn how to take care of their health.

Quick facts

Study typeInterventional
Ages16 Years to 20 Years
SexAll
Enrollment70 (estimated)
SponsorAnkara Yildirim Beyazıt University
Academic / other
Locations2 sites (Ankara, Ankara Yenimahalle and 1 other locations)
StatusRecruiting
StartedAugust 29, 2024
Main results expectedJanuary 30, 2025
Study endsMarch 30, 2025
Registry record updatedJanuary 31, 2025
Trial IDNCT06433401 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adolescents aged 16-20 with a diagnosis of congenital heart disease who have been under follow-up care for at least one year.

Probably not a fit

Patients who may not benefit from this study include those who cannot communicate in Turkish or have mental disabilities that hinder communication.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the impact of a structured transition care model on adolescents with congenital heart disease as they move from pediatric to adult healthcare systems. It aims to enhance their readiness for adult care, improve self-management skills, and raise awareness about the importance of regular medical follow-ups. The intervention includes training materials such as brochures, posters, and slide presentations to support the transition process. The study is designed as a randomized controlled trial to assess the effectiveness of this approach.

Why it matters

Potential benefit: If successful, this study could significantly improve the health outcomes and quality of life for adolescents with congenital heart disease as they transition to adult care.

How similar studies have gone: Other studies have shown success with similar transitional care approaches, indicating potential for positive outcomes in this population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Voluntarily agree to participate in the research
* To be between the ages of 16-20,
* Having a diagnosis of congenital heart disease,
* Being followed up with a diagnosis of congenital heart disease for at least one year in the polyclinics where the study was conducted,
* To be able to communicate in Turkish,
* Not having any mental deficiency that may prevent communication

Exclusion Criteria:

* Refusing to participate in the research,
* Not being able to communicate in Turkish,
* Not showing up regularly for follow-ups,
* Having any mental disability that may prevent communication

Where it's running

  • Republic of Turkey Ministry of Health Ankara Etlik City Hospital
    Ankara, Turkey (Türkiye)
    Recruiting
  • Republic of Turkey Ministry of Health Ankara Etlik City Hospital
    Ankara, Ankara Yenimahalle, Turkey (Türkiye)
    Not yet recruiting

Study contacts

  • Principal investigator: Tutku KIRÇI TEMİZ, PhD s. — Ankara Yildirim Beyazıt University
  • Study coordinator: Tutku KIRÇI TEMİZ, PhD s.
  • Email: tutkukrc29095@gmail.com
  • Phone: +905064278982

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.